Feed / NHC

National HealthCare Corporation

NHC

Healthcare · 221.79 -2.6% today

Participation confirmed · construction unavailableMarket checked 7 Oct, 15:55 GMT-4

Market read

National HealthCare Corporation's move is spreading beyond its market group.

The latest filing is mixed. 13 of 15 group members are active now; 5 filing-linked outsiders are moving with the group, and 0 of 0 directly disclosed connections are confirming.

What changed
  • Revenue increased 2.2% versus the comparable filing period.
Company-2.6% todayVolume comparison unavailable
Market group13 of 15 activeHealthcare REITs · active
Disclosed network0 of 4 confirmingNo filing-linked name is confirming now
What would change this read
  • At least 10 of 15 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • VTR remains aligned with the group in the next market snapshot.

Invalidation: The live read weakens if participation falls to 5 of 15 members or fewer.

Watch this read

Research brief

The story so far

Healthcare · Medical Care Facilities

The latest filing is mixed. 13 of 15 group members are active now; 5 filing-linked outsiders are moving with the group, and 0 of 0 directly disclosed connections are confirming.

Evidence that supports
  • Revenue increased 2.2% versus the comparable filing period.
  • Operating cash flow covered net income at 1.74x, improving versus the comparable period.
Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • At least 10 of 15 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • VTR remains aligned with the group in the next market snapshot.

Company research

Understand the business, not just the ticker

As of Oct 21, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods9
Price observations346
Usable filing statements29
Verified relationships1
Evidence supporting the case
  • Latest annual revenue changed +16.1% year over year.
  • Operating margin changed +1.6 percentage points in the latest annual period.
  • Operating cash flow covered net income at 1.54x in the latest annual period.
Evidence challenging the case

No qualifying adverse evidence was identified; that is not proof there is no downside.

Questions before a position
  • EV/sales is 17% above the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context

Price as of Oct 7, 2026

221.41
6m+28.5%12m+86.9%24m—
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$1.1B+4.5%$8.99+0.3%
2022-12-31$1.1B+1.1%$1.45+0.2%
2023-12-31$1.1B+5.1%$4.34-0.5%
2024-12-31$1.3B+14.5%$6.53+1.4%
2025-12-31$1.5B+16.1%$7.67+0.3%

What management says matters

Persistent and emerging business drivers

Credit and interest ratespositive · 2 filings
“The increase in non-GAAP earnings for the three months ended March 31, 2026 compared to the same period in 2025 was primarily due to a slight operating margin increase, a reduction of interest expense, and a favorable income tax rate for the quarter.”
10-Q · May 7, 2026 ↗

Valuation discipline

Descriptive valuation snapshot

Price/sales 2.3× · EV/sales 2.2×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

221.79-2.6% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 7 Oct, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for NHC. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Latest filing assessment · baseline

The latest filing presents a mixed picture

10-Q filed 2026-05-07 against the comparable filing from 2025-05-08.

mixed
OperationsmixedEvidence score +1
liquidityconstructiveEvidence score +1
valuationmixed

What improved

  • Revenue increased 2.2% versus the comparable filing period.
  • Operating cash flow covered net income at 1.74x, improving versus the comparable period.

What weakened

No thresholded deterioration was identified.

Filing receipts

“The increase in non-GAAP earnings for the three months ended March 31, 2026 compared to the same period in 2025 was primarily due to a slight operating margin increase, a reduction of interest expense, and a favorable income tax rate for the quarter.”

“When comparing net patient revenues for the first quarter of 2026 to the prior year period, the percentage increase was impacted due to a one-time Missouri retroactive Medicaid rate increase of $5,015,000 recorded in the first quarter of 2025.”

“Percentage of Net Operating Revenues Three Months Ended March 31 2026 2025 Net operating revenues 100.0 % 100.0 % Costs and expenses: Salaries, wages, and benefits 61.6 61.0 Other operating 23.9 24.7 Facility rent 3.1 3.1 Depreciation and amortization 3.0 3.0 Total costs and expenses 91.6 91.8 Income from operations 8.4 8.2 Non–operating income 1.0 1.1 Interest expense (0.1 ) (0.6 ) Unrealized gains on marketable equity securities 2.4 3.0 Income before income taxes 11.7 11.7 Income tax provision (2.2 ) (3.1 ) Net income 9.5 8.6 Net income attributable to noncontrolling interest (0.1 ) (0.0 ) Net income attributable to stockholders of NHC 9.4 % 8.6 % Three Months Ended March 31, 2026 Compare...”

Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.

Business ecosystem

The relationships behind NHC

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 4 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

NHC is currently a Follower in the organic co-movement group Healthcare REITs. This group is discovered from market behaviour rather than assigned from an industry taxonomy. No verified filing-linked names are available yet.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.